NCT00035542已完成3 期
A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
Bristol-Myers Squibb50 个研究点 分布在 1 个国家开始时间: 2001年12月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 试验地点
- 50
研究概览
简要总结
The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 9 Years 至 16 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Children ages 9-16 years with a diagnosis of type 2 diabetes mellitus who are not adequately controlled with diet and exercise, with or without oral hypoglycemic therapy, and have an HbA1c greater than 6.4%
排除标准
- 未提供
研究者
研究点 (50)
Loading locations...
相似试验
进行中（未招募）
不适用
Trial for Reliability of Urodynamics SysTemUrodynamicsUrologic DiseasesNCT05694793Bright Uro28
招募中
早期 1 期
Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid TumorsPancreatic NeoplasmsOther Solid TumorsNCT06577532Ruijin Hospital56
招募中
1 期
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune DiseasesAutoimmune DiseasesNCT06747156Ruijin Hospital66
已完成
3 期
Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)Crohn's DiseaseNCT00805766Tanabe Pharma Corporation39
终止
1 期
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 DiabetesType 2 Diabetes MellitusNCT02020616Eli Lilly and Company60